LONDON – A new mouse model for bipolar disorder is now available. The mouse, which has decreased activity of an enzyme already suspected of involvement in the development of bipolar disorder, will help researchers to identify new drugs to treat this condition, which affects 1 in 100 people.
LONDON – An antibody to a component of the complement cascade may have the potential to provide a new treatment for bacterial meningitis – if the company that manufactures it will release enough of it to allow large-scale trials to take place.
